Related Experiment Video
Updated: Jul 30, 2025

Evaluation of the Impact of Protein Aggregation on Cellular Oxidative Stress in Yeast
Published on: June 23, 2018
The Toxicity of Protein Aggregates: New Insights into the Mechanisms
Alessandra Bigi1, Eva Lombardo1, Roberta Cascella1
1Department of Experimental and Clinical Biomedical Sciences, Section of Biochemistry, University of Florence, 50134 Florence, Italy.
Abstract:
The aberrant aggregation of specific peptides and proteins is the common feature of a range of more than 50 human pathologies, collectively referred to as protein misfolding diseases [...].
Insights
Protein misfolding diseases, affecting over 50 human pathologies, are characterized by aberrant peptide and protein aggregation. Understanding these aggregation mechanisms is crucial for developing effective treatments.
Area of Science:
- Biochemistry
- Molecular Biology
- Neuroscience
Background:
- Protein misfolding diseases encompass over 50 human pathologies.
- Aberrant aggregation of peptides and proteins is a common pathological hallmark.
- These diseases present significant challenges in diagnosis and treatment.
Discussion:
- Investigating the molecular mechanisms underlying protein aggregation is critical.
- Therapeutic strategies often target the prevention or clearance of misfolded protein aggregates.
- The diversity of protein misfolding diseases necessitates tailored therapeutic approaches.
Key Insights:
- Specific peptides and proteins misfold and aggregate in various human diseases.
- Protein aggregation is a central pathogenic event in these conditions.
- Early detection and intervention are key to managing disease progression.
Outlook:
- Further research into protein aggregation pathways may reveal novel therapeutic targets.
- Developing diagnostic tools to identify specific protein aggregates is an ongoing area of research.
- Advancements in understanding protein misfolding could lead to treatments for neurodegenerative and other diseases.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Protein Denaturation
Protein-protein Interfaces
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...

